Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
About About Retatrutide Retatrutide (LY3437943) is a first-in-class triple-agonist peptide that simultaneously activates the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR)
The effects that sit outside the trial tables Menstrual-cycle changes are widely discussed in patient communities, including irregular or doubled cycles during rapid loss. Trials did not pre-specify them, so the adverse-event tables cannot estimate incidence
Monitor Your Body : Observe for any side effects, such as nausea or injection site reactions, and consult with your provider if you have concerns
and how they may come up for women navigating midlife
US$ 26.84
US$ 26.85
US$ 25.01
US$ 29.06
US$ 26.72
US$ 26.67
US$ 24.23
US$ 22.34
